PDS Biotechnology Corporation
PDS Biotechnology Corporation (NASDAQ: PDSB) is trading at $0.74, about ₹71 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 3.00% today. Indian residents can buy PDS Biotechnology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$0.73
Today's high
$0.77
52 week low
$0.20
52 week high
$1.55
PDSB opened at $0.76, closed previously at $0.77, and has traded between $0.20 and $1.55 over the past 52 weeks.
About
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.
Key statistics
Avg. volume
14.27M
Market cap
$41.54M
P/E Ratio
-1.16
Price-to-sales ratio
0.00
Enterprise value
$25.92M
Free cash flow yield
-77.72%
Debt-to-equity ratio
-1.22
Return on equity
-372.85%
ROIC
-116.55%
Beta
1.45
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$0.74
Free cash flow
-$27.75M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$30.30M
Revenue growth
0.00%
Similar securities
This is not an investment recommendation
How to buy PDS Biotechnology from India
Indian residents can buy PDS Biotechnology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for PDS Biotechnology and place an order
Find PDS Biotechnology by name or by its ticker, PDSB, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. PDS Biotechnology trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your PDS Biotechnology position in USD and INR. PDS Biotechnology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in PDS Biotechnology from India
Trading and taxes when buying PDS Biotechnology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePDS Biotechnology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy PDS Biotechnology stock?
Yes. PDS Biotechnology (PDSB) has been listed on NASDAQ since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one PDS Biotechnology share cost in rupees?
One PDS Biotechnology share is $0.74 — about ₹71 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the PDS Biotechnology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying PDS Biotechnology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of PDS Biotechnology?
Yes. One PDS Biotechnology share is $0.74, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in PDS Biotechnology.
How are gains on PDS Biotechnology shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the PDS Biotechnology price. Paasa issues a capital-gains statement for your return.
Does PDS Biotechnology pay a dividend?
No. PDS Biotechnology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade PDS Biotechnology from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on PDS Biotechnology shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare PDS Biotechnology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your PDS Biotechnology holding, its cost and its closing value.
How do I sell PDS Biotechnology and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.